Agilent Technologies (BSP:A1GI34) Total Liabilities : R$23,411 Mil (As of Jan. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Agilent Technologies Total Liabilities?

Agilent Technologies's Total Liabilities for the quarter that ended in Jan. 2024 was R$23,411 Mil.

Agilent Technologies's quarterly Total Liabilities increased from Jul. 2023 (R$24,564.16 Mil) to Oct. 2023 (R$24,864.92 Mil) but then declined from Oct. 2023 (R$24,864.92 Mil) to Jan. 2024 (R$23,410.63 Mil).

Agilent Technologies's annual Total Liabilities declined from Oct. 2021 (R$29,459.15 Mil) to Oct. 2022 (R$27,452.73 Mil) and declined from Oct. 2022 (R$27,452.73 Mil) to Oct. 2023 (R$24,864.92 Mil).

Agilent Technologies Total Liabilities Historical Data

The historical data trend for Agilent Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Agilent Technologies Total Liabilities Chart

Agilent Technologies Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Liabilities

Get a 7-Day Free Trial

19,204.08

26,742.68

29,459.15

27,452.73

24,864.92

Agilent Technologies Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Liabilities	Get a 7-Day Free Trial															27,570.58	25,162.74	24,564.16	24,864.92	23,410.63

Agilent Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Agilent Technologies's Total Liabilities for the fiscal year that ended in Oct. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	8104.608	+	(13827.886	+	2411.664
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	520.758)
	=	24,865

Total Liabilities	=	Total Assets (A: Oct. 2023 )	-	Total Equity (A: Oct. 2023 )
	=	54416.652	-	29551.735
	=	24,865

Agilent Technologies's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7952.729	+	(12566.001	+	2390.246
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	501.656)
	=	23,411

Total Liabilities	=	Total Assets (Q: Jan. 2024 )	-	Total Equity (Q: Jan. 2024 )
	=	53844.454	-	30433.822
	=	23,411

Agilent Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of Agilent Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Agilent Technologies (BSP:A1GI34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Agilent Technologies Inc (BSP:A1GI34) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

A:USA A:Mexico 1A:Italy AG8:Germany

Address

5301 Stevens Creek Boulevard, Santa Clara, CA, USA, 95051

Website

https://www.agilent.com

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Agilent Technologies (BSP:A1GI34) Headlines

No Headlines